The House voted late on March 4 to approve the Coronavirus Preparedness and Response Supplemental Appropriations Act (HR 6074) that would make $8.3 billion of new funding available for a “robust response” to the COVID-19 coronavirus, including vaccine and treatment development, support for state and local health agencies, and loans for small businesses impacted by the virus.